Page last updated: 2024-09-03

y 27632 and Neovascularization, Optic Disc

y 27632 has been researched along with Neovascularization, Optic Disc in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, L; Cui, Y; Guo, X; Huang, Q; Huang, X; Li, B; Wang, W; Weng, J; Zhang, S1
Fang, X; Ikuno, Y; Ueno, M; Yamashita, T1

Other Studies

2 other study(ies) available for y 27632 and Neovascularization, Optic Disc

ArticleYear
Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
    American journal of physiology. Heart and circulatory physiology, 2020, 03-01, Volume: 318, Issue:3

    Topics: Amides; Animals; Aorta; Capillary Permeability; Glycation End Products, Advanced; Mice; Mice, Knockout; Microfilament Proteins; Neovascularization, Pathologic; Phosphorylation; Pyridines; Receptor for Advanced Glycation End Products; Retina; Retinal Neovascularization; Signal Transduction

2020
RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Current eye research, 2011, Volume: 36, Issue:11

    Topics: Amides; Animals; Animals, Newborn; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Intravitreal Injections; Mice; Mice, Inbred C57BL; Oxygen; Pyridines; Retina; Retinal Neovascularization; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Treatment Outcome

2011